Japan MHLW Establishes New Flu Policy Guidance
This article was originally published in PharmAsia News
The Minister of Health, Labor and Welfare Yoichi Masuzoe June 19 announced a new policy to prepare for the second wave of flu infection, estimated to arrive during the fall to winter session. The new policy calls for patients with light flu symptoms to rest at home, and all medical facilities should treat new flu cases. MHLW also announced a halt in seasonal flu vaccine manufacturing and a start of new flu vaccine production from mid-July. The Minister estimates that within the year, four Japanese vaccine makers will produce vaccines for 2.5 million people, and new flu vaccinations will be available in October. Japan has yet to decide who will be among the first to be vaccinated. (Click here for more - Japanese language
You may also be interested in...
The pharma giants are joining forces to help the UK reach its ambitious target of testing 100,000 people a day for coronavirus by the end of April.
Angelini is looking to take its recently-acquired ThermaCare brand to the next level by establishing a direct base in Germany to market the product and through a new distribution deal with Norway's Navamedic.
BD and BioMedomics have released a new rapid point-of-care test that can detect antibodies in blood to confirm current or past exposure to COVID-19.